title: Suppressing effects of sunitinib on allergic rhinitis: previously undefined side effects with therapeutic potential.
authors.affiliation: Department of Medical Oncology, Erasmus Medical Center, University Hospital, Rotterdam, The Netherlands. k.eechoute@erasmusmc.nl
authors.forename: Karel
authors.initials: K
authors.lastname: Eechoute
authors.forename: Monika
authors.initials: M
authors.lastname: van Zonneveld
authors.forename: Paul L A
authors.initials: PL
authors.lastname: van Daele
authors.forename: Roy Gerth
authors.initials: RG
authors.lastname: van Wijk
authors.forename: Ron H J
authors.initials: RH
authors.lastname: Mathijssen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D011758:Pyrroles / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000378:metabolism; D000077210:Sunitinib
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D007073:Immunoglobulin E; D019009:Proto-Oncogene Proteins c-kit; D000077210:Sunitinib